Literature DB >> 3919979

I-A restricted activation by T cell lines of anti-tuberculosis activity in murine macrophages.

G A Rook, B R Champion, J Steele, A M Varey, J L Stanford.   

Abstract

Tuberculosis and leprosy remain two of the world's most significant diseases. Immunity involves the activation of macrophages by lymphokines but the details are unknown because there has been no objective assay for the relevant effector function using human pathogens. We previously reported the use of tritiated-uracil uptake by surviving mycobacteria as a measure of the anti-mycobacterial effect of human monocytes. We describe here the use of a modification of this assay to measure control of the proliferation of Mycobacterium tuberculosis in murine peritoneal macrophages. A bacteriostatic effect can be induced in macrophages infected with M. tuberculosis, by adding small numbers of Ly 1 +2- T cells from in vitro lines derived from immunized mice. The phenomenon is dependent on compatibility at the I-A locus of the major histocompatibility complex (MHC) and mediated by soluble factors. Such T cells also recognise and activate macrophages infected with other mycobacterial pathogens. Thus, T cells recognising shared mycobacterial antigens are active. The findings have implications for MHC linked susceptibility to mycobacterioses and the hypothesized ability of cross-reactive environmental mycobacteria to abrogate or pre-empt the protective efficacy of subsequent BCG vaccination.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3919979      PMCID: PMC1577140     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

1.  Three forms of delayed skin-test response evoked by mycobacteria.

Authors:  G A Rook
Journal:  Nature       Date:  1978-01-05       Impact factor: 49.962

2.  Growth of two strains of Mycobacterium bovis (BCG) in athymic mice.

Authors:  K Takeya; K Nomoto; S Muraoka; S Shimotori; T Taniguchi; T Miyake
Journal:  J Gen Microbiol       Date:  1977-06

3.  Preliminary demonstration of human tuberculoimmunity in vitro.

Authors:  A J Crowle; M May
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

4.  Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis.

Authors:  C E Palmer; M W Long
Journal:  Am Rev Respir Dis       Date:  1966-10

5.  Auto-anti-idiotypic antibodies inhibit T-cell-mediated hypersensitivity in BCG-infected mice.

Authors:  V Colizzi; M Giuntini; C Garzelli; M Campa; G Falcone
Journal:  Cell Immunol       Date:  1983-08       Impact factor: 4.868

6.  HLA-DR-associated genetic control of the type of leprosy in a population from surinam.

Authors:  W van Eden; R R de Vries; J D'Amaro; I Schreuder; D L Leiker; J J van Rood
Journal:  Hum Immunol       Date:  1982-07       Impact factor: 2.850

7.  Genetic control of cell-mediated immunity in the rat. III. T cells restricted by the RT1.A locus recognize viable Listeria but not isolated bacterial antigens.

Authors:  T W Jungi; T J Gill; H W Kunz; R Jungi
Journal:  J Immunogenet       Date:  1982-12

8.  Demonstration in tissue culture of lymphocyte-mediated immunity to tuberculosis.

Authors:  R J Patterson; G P Youmans
Journal:  Infect Immun       Date:  1970-06       Impact factor: 3.441

9.  H-2-linked gene(s) influence the granulomatous reaction to viable Mycobacterium lepraemurium in the mouse.

Authors:  O Closs; M Løvik; H Wigzell; B A Taylor
Journal:  Scand J Immunol       Date:  1983-07       Impact factor: 3.487

10.  Protection against Mycobacterium tuberculosis infection by adoptive immunotherapy. Requirement for T cell-deficient recipients.

Authors:  I M Orme; F M Collins
Journal:  J Exp Med       Date:  1983-07-01       Impact factor: 14.307

View more
  35 in total

1.  Cellular interactions in bovine tuberculosis: release of active mycobacteria from infected macrophages by antigen-stimulated T cells.

Authors:  E Liebana; A Aranaz; F E Aldwell; J McNair; S D Neill; A J Smyth; J M Pollock
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

2.  Characterization of T cells that confer a high degree of protective immunity against tuberculosis in mice after vaccination with tumor cells expressing mycobacterial hsp65.

Authors:  C L Silva; M F Silva; R C Pietro; D B Lowrie
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant gamma-interferon on human monocytes and murine peritoneal macrophages.

Authors:  G A Rook; J Steele; M Ainsworth; B R Champion
Journal:  Immunology       Date:  1986-11       Impact factor: 7.397

4.  Evolution of CD4 T-cell subsets following infection of naive and memory immune mice with Mycobacterium tuberculosis.

Authors:  J P Griffin; I M Orme
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

5.  Activation of mouse peritoneal macrophages by mannophosphoinositides of mycobacteria.

Authors:  P K Mehta; G K Khuller
Journal:  Med Microbiol Immunol       Date:  1989       Impact factor: 3.402

Review 6.  Is macrophage death on the field of battle essential to victory, or a tactical weakness in immunity against tuberculosis?

Authors:  D B Lowrie
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

7.  Responsiveness to live M. tuberculosis, and common antigens, of sonicate-stimulated T cell lines from normal donors.

Authors:  G A Rook; J Steele; S Barnass; J Mace; J L Stanford
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330

Review 8.  Immunological study of the defined constituents of mycobacteria.

Authors:  J Ivanyi; K Sharp; P Jackett; G Bothamley
Journal:  Springer Semin Immunopathol       Date:  1988

9.  Fate of Mycobacterium tuberculosis within murine dendritic cells.

Authors:  K A Bodnar; N V Serbina; J L Flynn
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

10.  Induction and expression of protective T cells during Mycobacterium avium infections in mice.

Authors:  R Appelberg; J Pedrosa
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.